SCIg may represent a safer alternative for patients who are at risk of thromboembolic events. Methods Our aim is to compare the safety profiles of SCIg and IVIg using a large cohort of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback